Expert Opinion on Drug Discovery- Impact Score, Overall Ranking, h-index, SJR, Rating, Publisher, ISSN, and Other Important Metrics

Aim and Scope

Expert Opinion on Drug Discovery (ISSN 1746-0441 [print], 1746-045X [electronic]) is a peer-reviewed, international journal publishing review articles on novel technologies involved in the drug discovery process, leading to new leads and reduced attrition rates. Each article is structured to incorporate the author’s own expert opinion on the scope for future development.

About Expert Opinion on Drug Discovery

Expert Opinion on Drug Discovery is a journal covering the technologies/fields/categories related to Drug Discovery (Q1). It is published by Informa Healthcare. The overall rank of Expert Opinion on Drug Discovery is 3959. According to SCImago Journal Rank (SJR), this journal is ranked 1.023. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 68. The best quartile for this journal is Q1.

The ISSN of Expert Opinion on Drug Discovery journal is 1746045X, 17460441. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Expert Opinion on Drug Discovery is cited by a total of 1793 articles during the last 3 years (Preceding 2021).

Expert Opinion on Drug Discovery Impact Score 2021-2022

The impact score (IS) 2021 of Expert Opinion on Drug Discovery is 5.73, which is computed in 2022 as per its definition. Expert Opinion on Drug Discovery IS is increased by a factor of 1.13 and approximate percentage change is 24.57% when compared to preceding year 2020, which shows a rising trend. The impact score (IS), also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Expert Opinion on Drug Discovery Impact Score 2022 Prediction

IS 2021 of Expert Opinion on Drug Discovery is 5.73. If the same upward trend persists, impact score may rise in 2022 as well.

Expert Opinion on Drug Discovery h-index

 

Expert Opinion on Drug Discovery has an h-index of 68. It means 68 articles of this journal have more than 68 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.

Expert Opinion on Drug Discovery ISSN

The ISSN of Expert Opinion on Drug Discovery is 1746045X, 17460441. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Expert Opinion on Drug Discovery Rank and SCImago Journal Rank (SJR)

The overall rank of Expert Opinion on Drug Discovery is 3959. According to SCImago Journal Rank (SJR), this journal is ranked 1.023. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

Expert Opinion on Drug Discovery Publisher

Expert Opinion on Drug Discovery is published by Informa Healthcare. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2006-2021. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.

Call For Papers

Visit the official website of the journal/conference to check the further details about the call for papers.

Abbreviation

The IS0 4 standard abbreviation of Expert Opinion on Drug Discovery is Expert Opin. Drug Discov.. This abbreviation ('Expert Opin. Drug Discov.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.

How to publish in Expert Opinion on Drug Discovery

If your research field is/are related to Drug Discovery (Q1), then please visit the official website of this journal.

Acceptance Rate

The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

• The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
• Peer review complexity and timeline.
• The mix of unsolicited and invited submissions.
• The time it takes from manuscript submission to final publication.
• And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.

Credits and Sources

• Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
• Journal Impact Factor, https://clarivate.com/